Accendra Health
202 hedge funds and large institutions have $349M invested in Accendra Health in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 71 reducing their positions, and 66 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less call options, than puts
Call options by funds: $2.15M | Put options by funds: $2.17M
1% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 71
2.81% less ownership
Funds ownership: 96.89% → 94.07% (-2.8%)
14% less funds holding
Funds holding: 234 → 202 (-32)
48% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 66
49% less capital invested
Capital invested by funds: $681M → $349M (-$332M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$17.5M |
| 2 |
Millennium Management
New York
|
+$13.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.1M |
| 4 |
CCM
Coliseum Capital Management
Rowayton,
Connecticut
|
+$9.78M |
| 5 |
Jane Street
New York
|
+$8.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$33.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$11.3M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$10.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.17M |
ACH Hedge Fund Activity: Q3 2025 in Review
202 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q3 2025, worth a combined $349M — down 49% from $681M a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of ACH and 34 opened new positions — a net loss of 32 holders — while 71 trimmed existing stakes and 70 added.
The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $17.5M. The largest seller was BlackRock, cutting an estimated $33.6M.
- 202 institutional investors held Accendra Health (ACH) as of Q3 2025, down from 234 in Q2 2025.
- Funds reported $349M of Accendra Health stock for Q3 2025, down 49% quarter-over-quarter.
- 34 funds opened new Accendra Health positions in Q3 2025 and 66 closed out, a net change of -32 holders.
- The largest Accendra Health buyer in Q3 2025 was Invenomic Capital Management, an estimated $17.5M added.
- The largest Accendra Health seller in Q3 2025 was BlackRock, an estimated $33.6M sold.
Based on aggregated 13F filings for Q3 2025.